LANOXICAPS Reviews (DIGOXIN)

Average Rating: 4.0 (1 Ratings)

Filter Results

Compare LANOXICAPS with similar:
 CARDIAC GLYCOSIDES

 Type: Brand name discontinued; available as generic

  

LANOXICAPS  (DIGOXIN):  Digoxin is used to treat heart failure, usually along with other medications. It is also used to treat certain types of irregular heartbeat (such as chronic atrial fibrillation). Treating heart failure may help maintain your ability to walk and exercise and may improve the strength of your heart. Treating an irregular heartbeat can decrease the risk for blood clots, an effect that may reduce your risk for a heart attack or stroke. Digoxin belongs to a class of medications called cardiac glycosides. It works by affecting certain minerals (sodium and potassium) inside heart cells. This reduces strain on the heart and helps it maintain a normal, steady, and strong heartbeat.   FDA Approval Date: 1982-07-26 (Sources: U.S. Centers for Medicare Services, FDA)

  

Results are sorted by Date added.

Key to Ratings: 1=LOW (I would not recommend taking this medicine.)
5=HIGH (this medicine cured me or helped me a great deal.)

Page: 1


RATING  REASONSIDE EFFECTS FOR LANOXICAPSCOMMENTSSEXAGEDURATION/
DOSAGE		DATE ADDED
 
 4   None but helpful regulation F 80
1X day		 2/14/2010
  

LANOXICAPS  (DIGOXIN):  Digoxin is used to treat heart failure, usually along with other medications. It is also used to treat certain types of irregular heartbeat (such as chronic atrial fibrillation). Treating heart failure may help maintain your ability to walk and exercise and may improve the strength of your heart. Treating an irregular heartbeat can decrease the risk for blood clots, an effect that may reduce your risk for a heart attack or stroke. Digoxin belongs to a class of medications called cardiac glycosides. It works by affecting certain minerals (sodium and potassium) inside heart cells. This reduces strain on the heart and helps it maintain a normal, steady, and strong heartbeat.   FDA Approval Date: 1982-07-26 (Sources: U.S. Centers for Medicare Services, FDA)

     

BACK TO TOP